Biosimilar Development solution center

31. 2022 Outsourcing Trends In Biopharmaceutical Manufacturing 6/15/2022

    The continued focus on productivity and efficiency is moving manufacturers to increasingly consider outsourcing activities. Biomanufacturers are spending more, demanding better technologies, and expressing greater optimism. This article shares the trends in outsourced activities, percentages of activities outsourced, outsourcing destinations, and offshoring.

32. De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector 6/2/2022

    Discover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.

33. Biosimilar Interchangeability: Regulatory & Practical Considerations 3/9/2022

    Biosimilar interchangeability refers to the possibility of exchanging the reference biological product with its biosimilar (or vice versa) or exchanging biosimilars of the same reference product. This article provides an up-to-date overview of regulatory and practical considerations regarding biosimilar interchangeability with an emphasis on the European perspective.

34. Imaging Large Volume Subcutaneous Injections To Inform Clinical Design 1/19/2022

    New higher volume, higher viscosity pharmaceutical formulations for subcutaneous injection, alternatives to traditional intravenous treatment, enable chronic disease therapy in alternate settings.

35. Training Devices And Patient Education Play A Crucial Role In The Self-Injection Drug Delivery Market 11/8/2021

    Understand the role training devices and patient education play with regard to self-injection therapies. Review the evolution of injection devices and prefilled syringes, the benefits of training devices combined with patient education, and an empirical look at patient training.

36. Capture Of Histidine-Tagged Molecules Using Biacore His Capture Kit 10/21/2021

    Find recommendations for immobilization of histidine-tagged molecules (ligands) by capture to an anti-histidine antibody covalently coupled to a sensor chip surface.

37. 3 Tips For Purifying His-Tagged Proteins 10/21/2021

    Tags simplify purification and enable scientists to use standard protocols while also improving the yield, purity, and solubility of the protein of interest.

38. Combining Ambr 15 Cell Culture With Octet Titer Measurements 10/20/2021

    This platform is an analytical instrument that can easily be implemented in cell line development labs to facilitate rapid determination of product yield.

39. Increase Drug Discovery Productivity, Optimize SPR Data Interpretation 9/17/2021

    The need to increase efficiency and productivity has led scientists to develop a machine learning solution that can optimize the way that developers analyze and characterize their early drug candidates.

40. 3 Successful Strategies For Protecting Your New Biopharma’s IP 9/1/2021

    Intellectual property is the lifeblood of new biopharma entities. Patent protection is necessary to secure investment, to build a solid foundation with opportunity for future growth, and to establish viability within a highly competitive landscape. This article addresses key patent-related considerations for startups and small or early-stage players in the life sciences arena.